The 2015 MCS-ICS (Medicinal Chemistry Section of the ICS) Award for Excellence in Medicinal Chemistry in Memory of Barry Cohen will be awarded to
for his highly significant contributions to synthetic and bioorganic chemistry, ranging from the discovery and development of new reactions, through total syntheses of many key natural product target molecules, to the design of new agents for treating major human diseases.
This international prize, which is awarded annually by the MCS-ICS, became possible thanks to an endowment fund donated by Teva Pharmaceutical Industries in memory of Mr. Abraham (Barry) Cohen, a longstanding member of Teva's Board of Directors, who greatly contributed to the development of the company over more than 20 years, and passed away in 2012. It is the third year that the prize is being awarded and Prof. Wender has joined now the growing list of distinguished award recipients, which includes Barry Trost of Stanford and Richard B. Silverman of Northwestern University.
The prize will be conferred during an official prize ceremony prior the lecture of Prof. Wender on Wednesday November 18, 2016, at the occasion of the 6th EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC'15), jointly organised this year with the 13th Annual Meeting of the MCS-ICS.